Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04801966
Title Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study (TAILOR)
Recruitment Recruiting
Gender both
Phase Phase 0
Variant Requirements No
Sponsors Peter MacCallum Cancer Centre, Australia
Indications

Advanced Solid Tumor

Therapies

Palbociclib

Alpelisib

Atezolizumab

Vemurafenib

Ribociclib

Talazoparib

Cobimetinib

Trametinib

Abemaciclib

Dabrafenib

Nivolumab

Binimetinib

Pembrolizumab

Encorafenib

Age Groups: adult | senior | child
Covered Countries


No variant requirements are available.